-
公开(公告)号:US20200172930A1
公开(公告)日:2020-06-04
申请号:US16631557
申请日:2018-07-19
Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
Inventor: Benjamin WIZEL , Martine HARVEY , Lucile WARTER , Kate LUISI
Abstract: The invention provides adenoviral vectors comprising transgenes encoding Chikungunya virus antigens. The vectors can be used to produce vaccines for the prophylaxis, amelioration and treatment of diseases caused by Chikungunya virus infections.